Advancements unveiled at International science conference

The International Science Conference, recently held at Bahmai Hospital in Euanseong on May 16-17, showcased cutting-edge developments in cancer diagnosis and treatment. The conference featured leading experts across various medical fields, including oncology, cardiology, emergency medicine, addiction treatment, and endocrinology, providing a comprehensive overview of the latest breakthroughs.

The Role of Surgery in Cancer Treatment

Surgical intervention remains a cornerstone of cancer treatment. Experts estimate that approximately 80% of cancer cases necessitate surgical procedures, with about 60% of cancers being directly treated through surgery. These procedures encompass a range of techniques, including natural orifice surgery, organ transplantation, and thermal ablation for cancers affecting organs like the liver and pancreas.

Da Vinci Robot: Revolutionizing Surgical Precision

The Da Vinci Robot is transforming surgical approaches, offering numerous advantages over traditional laparoscopic methods. Robot-assisted surgery leads to reduced blood loss, minimizes the risk of complications, shortens hospital stays, and facilitates quicker patient recovery. This technology is currently employed in a variety of procedures, including those for gastrointestinal, head and neck, obstetrics, and urological cancers.

Robot surgery has many advantages for patients. In particular, it reduces bleeding volume, minimizes the incidence of accidents and complications, shortens hospitalization, and helps patients recover.

Oncolytic Virus Therapy: A Novel Approach

A particularly groundbreaking area of cancer treatment discussed at the conference was oncolytic virus therapy. This innovative approach utilizes viruses to target and destroy cancer cells. one notable example is T-VEC (talimogene laherparepvec), a modified herpes simplex virus type 1, which received FDA approval in 2015 for the treatment of metastatic melanoma. Oncolytic viruses function as a form of immunotherapy, selectively infecting and lysing cancer cells while stimulating an immune response against the tumor.

The global oncolytic virus therapy market is projected to reach $649 million by 2027, growing at a CAGR of 22.4% from 2020, according to a report by Global Market Insights, Inc. This growth reflects the increasing recognition of oncolytic viruses as a promising cancer treatment modality.

Virus treatment is a form of immunotherapy to infect and kill cancer cells using viruses.

Beyond Viruses: exploring Othre Innovative Therapies

Along with oncolytic viruses, the conference highlighted the potential of vaccine therapies for malignant tumors. These vaccines can induce systemic tumor regression, leading to long-term remission and improved survival rates.Moreover, hyperthermia treatment, which involves heating tumors to suppress cancer cell growth and enhance their sensitivity to radiation and chemotherapy, was also discussed as a valuable adjunct therapy.

These advancements represent a significant step forward in the fight against cancer, offering new hope for patients and highlighting the importance of continued research and innovation in the field.